risedronate sodium
Active substance: risedronate sodium hemi-pentahydrate
TABLET, FILM COATED · RISEDRONATE SODIUM HEMI-PENTAHYDRATE 5 mg/1
United StatesActive
Marketing holder: Sun Pharmaceutical Industries, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- RISEDRONATE SODIUM HEMI-PENTAHYDRATE · 5 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-2507-753e-a924-ee3e06283f0f,01a1208e-4f60-7ea2-bb61-eef49508d768,01a1208e-4f7a-7f95-a992-953711372163,01a12095-dafe-7ebe-8e9e-98d426d2c7f0,01a1209d-5dbc-7d6a-8354-c1525c2e27fa;count=6 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 47335-666
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 47335-666 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 47335-666 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 47335-666 · Verified 2026-10-09 · open in source